This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Other. Active years: 2017.
Company Filing History:
1 out of 834,411 Years Active: 2017
Title: The Innovations of Torsten Lowin
Introduction
Torsten Lowin is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of biotechnology, particularly through his work on viral proteins. His innovative approach has led to advancements in understanding and manipulating viral structures.
Latest Patents
One of Torsten Lowin's key inventions is a modified VP1-capsid protein of parvovirus B19. This invention features a reduced phospholipase A2-like enzyme activity compared to the wild type VP1-capsid protein of parvovirus B19, which has the amino acid sequence of SeqID 1. This patent represents a significant step forward in the study of viral proteins and their applications.
Career Highlights
Throughout his career, Torsten Lowin has worked with prominent companies, including Novartis AG. His experience in the biotechnology sector has allowed him to develop innovative solutions that address complex challenges in virology.
Collaborations
Torsten has collaborated with esteemed colleagues such as Susanne Modrow and Markus Mobs. These partnerships have fostered a collaborative environment that enhances research and development in the field.
Conclusion
Torsten Lowin's contributions to biotechnology, particularly through his patented innovations, highlight his role as a significant inventor in the field. His work continues to influence the understanding of viral proteins and their potential applications.